SHAREHOLDERS' EQUITY

3 Months Ended

Sep. 30, 2025

Stockholders' Equity Note [Abstract]

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY

Accumulated Other Comprehensive Loss

Changes in the accumulated other comprehensive loss are comprised of the following amounts, shown net of taxes:

	Three Months Ended September 30, 2025
	Foreign currency translation adjustment		Post-employment benefits		Cash flow hedge		Total accumulated other comprehensive loss
Balance at June 30, 2025	$	(97,216)	$	(438)	$	5,968	$	(91,686)
Other comprehensive income	809		—		142		951
Amounts reclassified from accumulated other comprehensive (loss) income	(11)		1		(2,830)		(2,840)
Net current-period other comprehensive income (loss)	798		1		(2,688)		(1,889)
Balance at September 30, 2025	$	(96,418)	$	(437)	$	3,280	$	(93,575)

	Three Months Ended September 30, 2024
	Foreign currency translation adjustment		Post-employment benefits		Cash flow hedge		Total accumulated other comprehensive loss
Balance at June 30, 2024	$	(95,566)	$	(391)	$	18,391	$	(77,566)
Other comprehensive loss	(2,256)		—		(3,141)		(5,397)
Amounts reclassified from accumulated other comprehensive loss	—		(3)		(3,542)		(3,545)
Net current-period other comprehensive loss	(2,256)		(3)		(6,683)		(8,942)
Balance at September 30, 2024	$	(97,822)	$	(394)	$	11,708	$	(86,508)

Other Comprehensive Loss

Details of other comprehensive loss are as follows:

	Three Months Ended September 30,
	2025						2024
	Pre-Tax Amount		Tax Expense (Benefit)		Net Amount		Pre-Tax Amount		Tax (Benefit) Expense		Net Amount
Foreign currency translation adjustments	$	809	$	11	$	798	$	(2,266)	$	(10)	$	(2,256)
Post-employment benefits:
Reclassification of net actuarial gains and prior service cost into other income, net and included in net periodic pension costs	4		3		1		(5)		(2)		(3)
Unrealized gain (loss) on cash flow hedge	188		46		142		(4,159)		(1,018)		(3,141)
Reclassification of interest from cash flow hedge into interest (income) expense, net	(3,734)		(904)		(2,830)		(4,691)		(1,149)		(3,542)
Other comprehensive loss	$	(2,733)	$	(844)	$	(1,889)	$	(11,121)	$	(2,179)	$	(8,942)

Anti-dilutive Common Stock Equivalents

In the three month periods ended September 30, 2025 and September 30, 2024, stock options and stock appreciation rights related to 77 and 87 shares of common stock, respectively, were not included in the computation of diluted earnings per share for the periods then ended as they were anti-dilutive.